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The human subgroup C adenoviral E1B 55 kDa and E4 Orf6 proteins are required for efficient nuclear export of viral late mRNAs, but the
cellular pathway that mediates such export has not been identified. As a first step to develop a general approach to address this issue, we have
assessed the utility of cell-permeable peptide inhibitors of cellular export receptors. As both E1B and E4 proteins have been reported to
containing a leucine-rich nuclear export signal (NES), we synthesized a cell-permeable peptide containing such an NES. This peptide induced
substantial inhibition of export of the E1B protein, whereas a control, non-functional peptide did not. However, under the same conditions,
the NES peptide had no effect on export of viral late mRNAs. These observations establish that viral late mRNAs are not exported by
exportin1, as well as the value of peptide inhibitors in investigation of mRNA export regulation in adenovirus-infected cells.
D 2005 Elsevier Inc. All rights reserved.Keywords: Adenoviral E1B 55 kDa protein; mRNA export; Exportin1; Peptide InhibitorIntroduction
The selective transport of viral late mRNAs from the
nucleus and cytoplasm and concomitant inhibition of cel-
lular mRNA export that are characteristic of the late phase
of human, subgroup C adenovirus infection require the viral
E1B 55 kDa and E4 Orf6 proteins (reviewed in Dobner and
Kzhyshkowska, 2001; Flint and Gonzalez, 2003). Genetic
experiments have implicated the complex containing these
viral early proteins that is formed in infected cells (Sarnow
et al., 1984) in regulation of mRNA export (Bridge and
Ketner, 1990; Cutt et al., 1987). Furthermore, selective
export of viral late mRNAs has been correlated with the E4
Orf6 protein-dependent localization of the E1B protein to
the peripheral zones of viral replication centers (Gonzalez
and Flint, 2002; Ornelles and Shenk, 1991), which are the
sites of synthesis, and at least initial processing, of viral late
pre-mRNAs (Bridge et al., 1996; Pombo et al., 1994;0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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Pettersson, 1996). In cells infected by an adenovirus type
5 (Ad5) mutant carrying a small insertion in the E1B 55 kDa
protein coding sequence that inhibits interaction with the E4
protein, export of viral late mRNAs is impaired, and the
association of the E1B with the E4 protein at peripheral
zones of replication centers is disrupted (Gonzalez and Flint,
2002). By contrast, the association with, and organization at,
replication centers of the E4 Orf6 protein are not altered
(Gonzalez and Flint, 2002). These observations suggest that
the E4 Orf6 protein is primarily responsible for recognition
of some unknown features of these specialized nuclear sites,
while the E1B 55 kDa protein directs viral late mRNAs for
nuclear export. The cellular export pathway by which viral
mRNAs leave the nucleus during the late phase of infection
has not been identified. However, properties of the E1B 55
kDa protein suggest several possible candidates.
Among the numerous cellular proteins with which the
E1B 55 kDa protein has been shown to associate in cells
infected by Ad5 are the E1B-Ap5 and pp32 proteins (Gabler
et al., 1998; Harada et al., 2002). The former, which was
identified by virtue of its direct binding to the E1B protein005) 7 – 17
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the heterogeneous nuclear ribonucleoprotein family (Gabler
et al., 1998). The E1B-Ap5 protein binds to human Tap
(Bachi et al., 2000), one subunit of the Tap-p15 (NFX1-
NFX2) heterodimer, which is a major export receptor for
mRNAs in eukaryotes (reviewed in Cullen, 2003; Vinci-
guerra and Stutz, 2004; Weis, 2002). The pp32 protein is a
ligand of the human HuR protein, which has been shown to
serve as an export adaptor for short-lived mRNAs encoded
by early response genes, such as c-fos (Brennan et al., 2000;
Gallouzi and Steitz, 2001). The pp32 protein is not itself an
export receptor. Rather it contains a leucine-rich nuclear
export signal (NES) analogous to that present in the human
immunodeficiency virus type 1 Rev protein, the first export
signal to be identified (Fischer et al., 1995; Fornerod et al.,
1997; Fukuda et al., 1997; Malim et al., 1989, 1991;
Pasquinelli et al., 1997). Like the Rev NES, that presents in
pp32 is recognized by the export receptor exportin1 (Crm1)
(Brennan et al., 2000). It is not known whether the
interactions of the E1B 55 kDa protein with these cellular
proteins are important for regulation of mRNA export in
Ad5-infected cells, although it has been reported that
overproduction of the E1B-Ap5 protein induces a modest
increase in the accumulation of viral late mRNAs in the
cytoplasm (Gabler et al., 1998).
The E1B 55 kDa protein itself contains an autonomous
leucine-rich NES, which is both necessary and sufficient for
exit of the viral protein from the nucleus in the absence of
other viral proteins (Kratzer et al., 2000) and in Ad5-
infected cells (Dosch et al., 2001). Such NES-dependent
export, and hence the shuttling activity of the E1B protein,
are inhibited by the HIV-1 Rev protein and leptomycin B, a
specific inhibitor of exportin1 (Dosch et al., 2001; Kratzer et
al., 2000). The E4 Orf6 protein has also been reported to
contain a leucine-rich NES required for shuttling of the E1B
55 kDa-E4 Orf6 protein complex in the absence of other
viral protein (Dobbelstein et al., 1997). In addition to its role
in export of specific cellular mRNAs described in the
previous paragraph, exportin1 transports unspliced and
partially spliced HIV-1 mRNAs that contain the Rev
recognition element from the nucleus to the cytoplasm
(Bogerd et al., 1998; Fischer et al., 1995; Fornerod et al.,
1997). This receptor has also been implicated in export of at
least some herpesviral mRNAs that lack introns (Soliman
and Silverstein, 2000a, 2000b). In conjunction, these
observations suggest that viral late mRNAs could leave
the nucleus via the exportin1 pathway.
Efforts to evaluate the functional importance of these
adenoviral export signals have yielded seemingly contra-
dictory findings and conclusions. Whether the E4 Orf6
protein NES directs efficient exportin1-dependent export is
not clear: under conditions in which the E1B 55 kDa protein
was sufficient to mediate export of a GST–NES–GFP
fusion protein, the E4 Orf6 NES failed to do so (Kratzer et
al., 2000). It has also been reported that, compared to the
E1B protein, the E4 protein shuttles between the nucleusand cytoplasm at a slow rate, and that such activity is only
partially inhibited by leptomycin B (Dosch et al., 2001).
Two groups of investigators have assessed the role of the E4
Orf6 NES using an assay in which deletion of the E4 coding
sequence from the viral genome was complemented by
transient synthesis of wild type or altered E4 Orf 6 proteins.
In one case, substitutions that blocked the function of the
NES were reported to be required for efficient accumulation
of viral late mRNAs in the cytoplasm (Weigel and
Dobbelstein, 2000), whereas in the other no effect on
synthesis of viral late proteins was observed (Rabino et al.,
2000). Bridge and colleagues also observed that inhibition
of exportin1 by leptomycin B blocked cytoplasmic accu-
mulation of the E4 and E1B 55 kDa proteins, but did not
reduce viral late protein synthesis (an indirect measure of
viral late mRNA export) (Carter et al., 2003; Rabino et al.,
2000). It has been argued that differences in such
experimental parameters as multiplicity of infection with
E4 mutant viruses, the concentrations of exogenous,
complementing E4 proteins achieved by different transient
expression protocols, and the concentration and duration of
leptomycin B treatment could account for these apparent
discrepancies (Bridge, 2000; Dobbelstein, 2000). It should
also be noted that the effects of NES mutations or drugs on
viral late mRNA export have never been examined directly.
The use of experimental surrogates, such as accumulation of
cytoplasmic mRNA or the efficiency of late protein
synthesis, could well be misleading. Any defect or delay
in entry into the late phase of infection would result in
reduced and delayed accumulation of both viral late mRNAs
and late proteins in the cytoplasm, even though viral late
mRNA export was not specifically inhibited. Furthermore,
when export of viral late mRNAs is impaired, for example,
in cells infected by E1B 55 kDa protein null mutants of
Ad5, the consequent decreases in viral late protein synthesis
result in secondary defects. In the first place, the efficiency
of ML transcription declines from about 16 h p.i. (Leppard,
1993; Pilder et al., 1986), presumably because of production
of reduced quantities of the viral IVa2 protein (Pardo-Mateos
and Young, 2004a, 2004b; Tribouley et al., 1994). Secondly,
late protein synthesis is reduced to a substantially greater
degree than expected from the decrease in the cytoplasmic
concentrations of the corresponding mRNAs (Harada and
Berk, 1999; Williams et al., 1986). This phenotype is most
likely a result of impaired synthesis of the viral L4 100 kDa
protein, which is necessary for efficient translation of all late
mRNAs (Hayes et al., 1990; Williams et al., 1986; Xi et al.,
2004).
Reagents that specifically inhibit each of the several
pathways by which macromolecules are exported from
mammalian cell nuclei would greatly facilitate elucidation
of the mechanism of selective export of adenoviral late
mRNAs. Knock-down of expression of mammalian genes
using small interfering RNAs can be both sufficiently
specific and effective (see Dykxhoorn et al., 2003; Hannon
and Rossi, 2004; Mittal, 2004). However, inhibition of
S.J. Flint et al. / Virology 337 (2005) 7–17 9essential export pathways by such reagents for the period
necessary to reach the late stage of adenovirus infection
could well induce cytotoxicity, or impair early steps in the
infectious cycle upon which entry into the late phase
depends. We have therefore assessed the feasibility of an
alternative approach that avoids such complications, the use
of cell-permeable peptides designed to inhibit particular
export pathways.Results
Design, uptake, and localization of peptide inhibitors of
exportin1
The nuclear export receptor exportin1 mediates export
from the nucleus of various proteins and of RNAs bound to
proteins, including unspliced and partially spliced human
immunodeficiency virus RNAs bound to the viral Rev
protein, U snRNAs, and 40S and 60S ribosomal subunits
(see Cullen, 2003; Mattaj and Englmeier, 1998; Pollard and
Malim, 1998; Weis, 2002 for reviews). In the presence of
Ran-GTP, exportin1 binds cargo proteins via recognition of
a short, leucine-rich nuclear export signal (NES). Peptides
containing such a sequence specifically block exportin1-
dependent export when microinjected into Xenopus oocytes
(Fischer et al., 1995; Pasquinelli et al., 1997) and when
translocated into human cells in culture via attachment to a
cell-permeable peptide (Gallouzi and Steitz, 2001). The
latter corresponded to residues 43–58 (the third helix) of the
Drosophila antennapedia protein, which had previously
been shown to enter living cells at high efficiency, even
when covalently linked to hydrophilic moieties (reviewed in
Derossi et al., 1998). We therefore designed an analogous
peptide inhibitor of exportin1 that comprised the 16 amino
acid antennapedia sequence described above, which has
been termed penetratin-1 (Derossi et al., 1994), linked to the
NES of the HIV-I Rev protein. A second, control peptide
contained an altered NES carrying substitutions of leucine
residues known to be essential for function of the export
signal (Malim et al., 1989, 1991). As illustrated in Fig. 1,
the penetratin-1 and NES sequences were linked via four
amino acids with small side chains, and both peptides were
biotinylated at their N-termini to allow detection withinFig. 1. Sequences of the NES and NESm peptides. The penetratin-1 (see
text) and NES segments of the NES and NESm peptides are indicated on
the primary sequences. The NES corresponds to that of the HIV-1 Rev
protein, amino acids 73–84 (Elfgang et al., 1999; Fischer et al., 1995;
Fukuda et al., 1997; Pasquinelli et al., 1997). The two NESm alanine
substitutions of leucine residues that are essential for the function of the
Rev NES (Malim et al., 1989, 1991) are shown in bold face.cells. Modification at this position was chosen, because it
has been established that a free N-terminus of the penetratin-
1 peptide is not required for efficient translocation across the
plasma membrane (Derossi et al., 1998). The modified
peptides were synthesized, purified, and characterized by
mass spectroscopy as described in Materials and methods.
We first assessed the entry into HeLa cells of the two
peptides, and their intracellular locations. Uninfected cells
were incubated in medium containing either the NES or the
NESm peptide (Fig. 1) for 2–4 h at 37 -C. They were then
prepared for immunofluorescence and stained with FITC-
avidin as described in Materials and methods. Untreated
cells exhibited faint cytoplasmic staining (Fig. 2, panels a
and e) reflecting their endogenous biotin content. The
uptake of both exogenous peptides was readily evident:
essentially all cells exposed to 25 or 50 AM of either
peptides were strongly stained with FITC-avidin (Fig. 2,
panels b–d and f–h). However, the peptides differed in their
intracellular locations. Although detectable in the cyto-
plasm, the NES peptide was concentrated at the nuclear
periphery (Fig. 2, panels b and c), the major site of
accumulation of exportin1 in mammalian cells, as well as
in budding and fission yeasts (Adachi and Yanagida, 1989;
Fornerod et al., 1997; Kudo et al., 1997). This peptide was
also observed concentrated at discrete, dot-like structures
within nuclei (arrows in Fig. 2, panel d), similar in
appearance to intranuclear structures reported to contain
exportin1 (Fornerod et al., 1997). By contrast, the NESm
peptide was not concentrated at either the nuclear rim or
within the nucleoplasm, but exhibited diffuse cytoplasmic
staining (Fig. 2, panels f–h). These observations suggest
that the NES peptide binds exportin1, while the substituted,
non-functional derivative does not.
The results shown in Fig. 2 also illustrate the reprodu-
cible observation that exposure of cells to either the NES or
the NESm peptide, for 4 h in the example shown, induced
no cytotoxicity or visible change in cell morphology, in
agreement with a previous report (Gallouzi and Steitz,
2001). Nor did entry of either peptide into Ad-5-infected
cells alter cell morphology (e.g., Fig. 3A).
Inhibition of exportin1-dependent export of the E1B 55 kDa
protein by the NES peptide
We wished to determine whether our NES peptide indeed
blocked exportin1-dependent export from the nucleus in
Ad5-infected cells. We therefore examined the effects of the
peptide on transport of the viral E1B 55 kDa protein from
the nucleus, a process previously established to be mediated
by exportin1 (Dosch et al., 2001; Kratzer et al., 2000),
initially using a modification of the classic heterokaryon
shuttling assay (Pin˜ol-Roma and Dreyfuss, 1992). In this
approach, HeLa cells were infected with Ad5 and plated
with an equal number of uninfected HeLa cells. At 12–14 h
after infection, infected and uninfected cells were fused as
described in Materials and methods. They were then
Fig. 2. Localization of the NES and NESm peptides in HeLa cells. HeLa cells were incubated with the concentrations of the NES or NESm peptides indicated
for 4 h at 37 -C. The peptides were labeled with FITC-avidin (green) and their locations then examined by immunofluorescence, as described in Materials and
methods. Nuclei were stained with DAP1 (red). Panels d and h show higher magnification views of parts of the fields shown in panels c and g, respectively. The
white arrows in panel d indicate nucleoplasmic dots containing the NES peptide.
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further protein synthesis, in the absence or presence of the
NES or control NESm peptides for 3–4 h at 37 -C. Infected
cells were then distinguished from their uninfected siblings
by virtue of the formation within them of characteristic
replication centers that contain the viral 72-kDa, single-
stranded DNA-binding protein (DBP) (Puvion-Dutilleul et
al., 1994; Reich et al., 1983; Sugawara et al., 1977;
Volderking and Klessig, 1986). The formation of such
structures, which appear as discrete dots or rings (Fig. 3A,
panels b, f, and j), depends on viral DNA synthesis
(Volderking and Klessig, 1986) and is restricted to
adenovirus-infected cells. Shuttling of the E1B 55 kDa
protein from infected to uninfected cell nuclei was therefore
examined by simultaneous labeling of this protein and the
DBP in syncytia formed as described above.
In infected cells identified by the presence of replication
centers, a significant fraction of the E1B protein was present
at these sites, colocalized with the DBP (Fig 3A, panels d, h,
and l), as reported previously (Gonzalez and Flint, 2002;
Ornelles and Shenk, 1991). In the absence of any peptide,
the E1B protein was readily detected in uninfected (i.e.,
DBP-lacking) nuclei present in syncytia with infected cell
nuclei (Fig. 3A, panels a–d), indicating that this viral
protein was exported from infected cell nuclei to the
syncytial cytoplasm prior to entry into uninfected cell
nuclei. Incubation of fused cells with the NES peptide
significantly inhibited shuttling of the E1B 55 kDa protein
(Fig. 3A, panels e–h), whereas the substituted NESm
peptide had little or no effect (Fig. 3A, panels i–l). The
results of quantification of several independent experiments
like that illustrated in Fig. 3A are summarized in Fig. 3B.
The NES peptide reduced the shuttling activity of the E1B
55 kDa protein by 60%, whereas the substituted derivative
was not inhibitory. These data established that the NES
peptide specifically blocked exportin1-dependent export ofthe E1B 55 kDa from Ad5-infected cell nuclei. However,
the inhibitory effect of this peptide was underestimated in
these experiments: to minimize subjectivity associated with
assessing nuclear E1B protein concentrations by immuno-
fluorescence, only syncytial, uninfected cell nuclei in which
E1B protein staining was no greater than the background
observed in non-syncytial, uninfected cells were counted as
negative. We therefore examined the effects of the peptides
on the cytoplasmic concentrations of the E1B protein by
immunoblotting.
HeLa cells infected with Ad5 were incubated from 13 to
15.5 h after infection with 50 AM NES or NESm peptide in
the presence of cycloheximide. Cytoplasmic fractions
isolated by extraction of cells with NP40 under conditions
that do not result in leakage of nuclear material (Yang et al.,
1996) contained no more than 10% of the total E1B 55 kDa
protein (data not shown), in agreement with previous
observations (Ornelles and Shenk, 1991; Smiley et al.,
1990). Exposure of the nuclear pellet to stronger detergents,
such as 1% (v/v) Tween 40 plus 0.5% (w/v) sodium
deoxycholate, released about the same quantity of additional
E1B protein, again as reported previously (Smiley et al.,
1990). However, treatment with these additional detergents
led to leakage of nuclear contents, as judged by recovery of
the viral 72 kDa DBP, which is exclusively nuclear in
location (e.g., Fig. 3A; Reich et al., 1983; Volderking and
Klessig, 1986) in the Tween 40/sodium deoxycholate
fraction (data not shown). We therefore compared the
concentrations of the E1B 55 kDa protein in cytoplasmic
fractions isolated using only NP40 by immunoblotting.
Despite a low concentration of E1B 55 kDa protein in this
fraction of untreated, Ad5-infected cells, a substantial
decrease in concentration induced specifically by the NES
peptide was readily evident (Fig. 4). Indeed, this peptide
inhibited nuclear export of the E1B 55 kDa protein by close
to 85%, as judged by quantification of immunoblot signals
Fig. 3. Specific inhibition of E1B 55 kDa protein shuttling by the NES peptide. (A) HeLa cells were infected with 10 p.f.u./cell Ad5 and plated with equal
number of uninfected HeLa cells after adsorption of the virus. Cells were fused at 14 h p.i. and incubated with 100 Ag/ml cycloheximide and the peptide
indicated (50 AM final concentrations) for 3 h at 37 -C. The viral 72 kDa and E1B 55 kDa proteins were examined by immunofluorescence as described in
Materials and methods. (B) The number of uninfected cell nuclei present in syncytia with Ad5-infected cell nuclei and the number within this population that
stained positive for the E1B 55 kDa protein (staining significantly above the background seen in non-syncytial, uninfected cells) were determined from data
collected in three independent experiments like that illustrated in panel A. At least 25 syncytial, uninfected cell nuclei were examined under each condition in
each experiment. The percentages of E1B protein-positive, uninfected nuclei present in the syncytia were then calculated. These values, which ranged from
40% to 58% for cells that had not been exposed to peptide, are expressed relative to that exhibited in each experiment by syncytial cells in the absence of either
peptide.
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Cycloheximide, which does not inhibit protein synthesis
completely (see Lewis and Mathews, 1980), was added to
culture medium at the same time as the peptides. It is
therefore likely that the small quantity of the E1B 55 kDa
protein detected in the cytoplasmic fraction of cells exposed
to the NES peptide represents newly-synthesized molecules
that have not yet entered the nucleus.Exportin1 is not required for efficient export of viral late
mRNAs
We next compared the export of viral late mRNAs from
the nucleus to the cytoplasm in untreated Ad5-infected
cells, in Ad5-infected cells incubated with the NES or
NESm peptides, and in cells infected with the E1B 55 kDa
protein null virus Hr6 (Ho et al., 1982; Williams et al.,
Fig. 4. Specific inhibition of export of the E1B 55 kDa protein from the
nucleus by the NES peptide. Cytoplasmic proteins recovered from equal
numbers of Ad5-infected cells that were untreated or incubated with 50 AM
NES or NESm peptides for 2.5 h were examined by sequential
immunoblotting with mouse monoclonal antibodies against the viral E1B
55 kDa protein and h-actin, as described in Materials and methods. The
results of quantification of E1B protein signals using h-actin as the internal
control in two experiments are summarized at the bottom of the figure. The
standard deviations for the E1B protein concentrations in NES and NESm
peptide-treated extracts relative to that observed in the untreated control
were 0.01 and 0.02, respectively.
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phase of infection, so that any effect of export of viral late
mRNAs could be readily detected. The concentrations of
cytoplasmic and nuclear penton and fiber mRNAs were
determined by using two-step RT-PCR. Reverse tran-
scription was first carried out with primers specific for
mature mRNAs: these primers were complementary to the
junctions between the third exon of the major late (ML)
tripartite leader sequence and the bodies of the viral
mRNAs. Relative cDNA, and hence mRNA, concentra-
tions were then measured by using real-time PCR to
amplify a sequence within the tripartite leader common to
all ML mRNAs, as described in Materials and methods.
Human h-actin mRNA was reverse transcribed and
amplified in the same reactions to provide an internal
control. No amplification of either the ML or the h-actin
sequences was observed when reverse transcriptase was
omitted from primer extension reactions (data not shown),
establishing that these assays detect only RNA.
Inhibition of exportin1 alters the nuclear to cytoplasmic
trafficking of many cellular proteins and of cellular RNAs
(see Introduction), and might therefore indirectly impair
synthesis or processing of adenoviral late mRNAs. We
therefore first examined the effects of the NES or NESm
peptides on the nuclear concentrations of penton and fiber
mRNAs. Under the conditions used in these experiments,
neither peptide significantly altered the nuclear concen-
trations of these viral late RNAs (Fig. 5A), indicating that
the reactions by which viral late mRNAs are synthesized
were not perturbed by the peptides. We next determined
the ratios of the steady concentrations of cytoplasmic and
nuclear viral mRNAs to a measure of export efficiency: as
discussed previously (Gonzalez and Flint, 2002), this
parameter provides a direct assay for mRNA export. As
expected (see Introduction), export of both the L2 penton
and the L5 fiber mRNA was impaired in Hr6- compared to
Ad5-infected cells (Fig. 5B). The degrees of inhibition
induced by the Hr6 mutation observed in these experi-
ments were similar to values we have obtained previouslyusing different assays (Gonzalez and Flint, 2002; Yang et
al., 1996). By contrast, incubation of Ad5-infected cells
with the NES or the NESm peptide did not induce
significant changes in the cytoplasmic to nuclear ratios
of either viral late mRNA (Fig. 5B). We can therefore
conclude from the results summarized in Fig. 5 that
inhibition of exportin1-dependent export by the NES
peptide did not reduce the efficiency of nuclear export of
viral late mRNAs.Discussion
The studies reported here establish the feasibility of
using peptide inhibitors to investigate the roles of cellular
export pathways in the adenoviral infectious cycle. Using
an NES-containing inhibitor of exportin1, we have con-
firmed that exportin1 mediates nucleocytoplasmic shutting
of the Ad5 E1B 55 kDa protein (Dosch et al., 2001;
Kratzer et al., 2000) and shown that the NES peptide
inhibits nuclear export of the E1B protein to a high degree,
if not completely (Fig. 4). Nevertheless, under the same
condition, the NES peptide had no effect whatsoever on
export of viral late mRNAs to the cytoplasm (Fig. 5). This
result confirms the finding based on use of leptomycin B
and an indirect measure of late mRNA export that
exportin1 is not the export receptor for viral late mRNAs
(Carter et al., 2003; Rabino et al., 2000). The observation
that export of cellular U snRNAs and ribosomal RNAs,
which have been reported to leave the nucleus using the
exportin1 receptor (reviewed in Cullen, 2003; Weis, 2002),
is not perturbed during the late phase of infection
(Castiglia and Flint, 1983; Smiley et al., 1990) is
consistent with this conclusion. It therefore appears that
the previously reported dependence of accumulation of
viral late mRNAs in the cytoplasm on the NES of the E4
Orf6 protein (Weigel and Dobbelstein, 2000) represents a
secondary consequence of defects in one or more earlier
steps in the infectious cycle. Indeed, both a delay in viral
DNA synthesis and reduced nuclear accumulation of late
mRNAs were observed when this NES was altered (Weigel
and Dobbelstein, 2000).
As translocation of the E1B 55 kDa protein into the
cytoplasm by exportin1 makes no contribution to selective
export of viral late mRNAs, such nuclear export is
presumably required for some other function(s) of this
adenoviral early protein. One possibility is regulation of
the activity and/or concentration of the cellular p53
protein. Indeed, Dobner and colleagues have recently
reported that substitutions of the leucine residues of the
E1B NES with alanines improved both inhibition of p53-
dependent transcription and transformation of baby rat
kidney cells by the E1B protein (Endter et al., 2005). In
conjunction with the viral E4 Orf6 protein, the E1B 55
kDa protein also induces accelerated turnover of the p53
protein (Nevels et al., 1999; Querido et al., 1997; Roth et
Fig. 5. The NES peptide does not alter the production or the efficiency of export of viral late mRNAs. HeLa cells were infected with 10 p.f.u./cell Ad5 or Hr6.
At 14 h p.i., the NES or NESm peptides (50 AM final concentrations) were added to sets of Ad5-infected cell monolayers and incubation at 37 -C continued for
4 h. The cells were harvested and nuclear and cytoplasmic RNA fractions purified as described previously (Gonzalez and Flint, 2002). The concentrations of
processed L2 penton and L5 fiber mRNAs present in cytoplasmic and nuclear fractions recovered from an equal number of cells were then determined by
reverse transcription and quantitative real-time PCR, as described in Materials and methods. The values obtained were corrected for any variations in cell
number or RNA recovery using the h-actin internal control. The relative concentrations of nuclear RNAs (panel A) and the ratios of cytoplasmic: nuclear late
mRNAs (panel B) were then calculated. The latter are expressed relative to those determined for Ad5-infected cells that were not exposed to peptide. The
values shown represent the results of 3 independent experiments, in each of which the mRNA concentrations were measured using at least two reverse
transcription reactions.
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which p53 degradation is induced is not fully understood,
but seems likely to depend on association of the viral
proteins with p53 and cellular proteins such as cullin 5,
Tbx1/Roc1/Hrt, and elongins B and C in a complex that
directs addition of polyubiquitin to p53 (Harada et al.,
2002; Querido et al., 2001). The cellular Hdm-2 protein(Mdm-2 in mice) is a critical regulator of the concentration
of p53 in uninfected cells. This protein binds to p53 and
ubiquinates both the tumor suppressor and itself, targeting
both proteins for degradation by the proteosome (reviewed
in Lakin and Jackson, 1999; Oren, 1999; Prives, 1998;
Ryan et al., 2001). Efficient degradation of p53 depends on
export from the nucleus (Dobbelstein et al., 1997; Freed-
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that in turn requires the E3 ubiquitin ligase activity of the
Hdm-2 protein (Boyd et al., 2000; Geyer et al., 2000). The
p53 tetramer is not efficiently exported from the nucleus
unless C-terminal lysine residues are ubiquinated, a
modification that is believed to expose export signals
(Stommel et al., 1999). Signals that result in stabilization
and activation of p53, such as those induced by DNA
damage, result in phosphorylation of p53 at specific N-
terminal Ser residues. These modifications inhibit inter-
action with Hdm-2 and render p53 temporarily refractory
to export and degradation. It is therefore possible that in
Ad5-infected cells, the E1B 55 kDa-E4 Orf6 protein-
containing complex effects export and degradation of
Hdm2-refractory p53 protein that accumulates in response
to synthesis of viral E1A proteins (reviewed in Braithwaite
and Russell, 2001). The E1B 55 kDa protein has also been
implicated in induction of degradation of components of
the cellular double-stranded break repair system (Stracker
et al., 2002) and in relocalization of p53 and the Wt1
tumor suppressor proteins to peripheral nuclear bodies in
transformed cells (Blair-Zajdel and Blair, 1988; Mahes-
waran et al., 1998; Zantema et al., 1985). It should be
possible to use peptide inhibitors like that described here
to evaluate the contribution of exportin1-dependent export
to these activities of the E1B 55 kDa protein.
The failure of the NES peptide (Fig. 5) as well as of
leptomycin B (Carter et al., 2003; Rabino et al., 2000) to
block export of viral late mRNAs from the nucleus indicates
that the E1B 55 kDa protein does not function as an NES-
containing adaptor for RNA export, analogous to the HIV
Rev protein (see Introduction). These observations also rule
out late mRNA export by a second route, that in which the
HuR RNA-binding protein is directed to exportin1 via the
HuR ligands and NES-containing proteins pp32 and April:
this pathway is also blocked by NES peptides (Gallouzi and
Steitz, 2001). However, HuR can also direct cellular
mRNAs synthesized from early response genes to a second
export receptor, transportin-2 (Gallouzi and Steitz, 2001).
This export mechanism depends on recognition of the amino
acid sequence required for nucleocytoplasmic shuttling of
the HuR protein (Fan and Steitz, 1998), to which trans-
portin-2 appears to bind directly (Gallouzi and Steitz, 2001).
Whether HuR and transportin-2 are responsible for export of
adenoviral late mRNAs has not been tested. As noted in the
Introduction, the E1B 55 kDa protein may interact with the
Tap export receptor via the E1B-Ap5 protein (Bachi et al.,
2000; Gabler et al., 1998). The Tap protein binds to FG
repeat-containing nucleoporins, such as Nup214/Can (Bachi
et al., 2000; Sugawara et al., 1977; Wiegand et al., 2002).
This interaction is facilitated by the p15 (NFX2) component
of the Tap-p15 heterodimer and required for mRNA export
(Bachi et al., 2000; Fribourg et al., 2001; Kang and Cullen,
1999; Katahira et al., 1999). Although Tap binds directly to
the constitutive transport element of unspliced RNAs of
some simple retroviruses (Gru¨ter et al., 1998; Kang andCullen, 1999), recognition of cellular mRNAs depends on
adaptors such as Ref/Aly, UAP56, and certain SR splicing
proteins (reviewed in Cullen, 2003; Stutz and Izaurralde,
2003; Vinciguerra and Stutz, 2004). It is therefore possible
that the E1B 55 kDa protein, which contains an RNP motif
that mediates binding to RNA in vitro (Horridge and
Leppard, 1998), and/or the E1B-Ap5 protein, function as
export adaptors for Tap-dependent export of viral, late
mRNAs. If Tap represents the major mRNA export receptor
in mammalian cells, as it does in simpler eukaryotes
(reviewed in Stutz and Izaurralde, 2003), hijacking of Tap
for export of viral late mRNAs would account for the
inhibition of export of cellular mRNAs during the late phase
of infection. Experiments are therefore in progress to
identify peptides that specifically inhibit the transportin-2
and Tap export receptors.Materials and methods
Cells and virus
HeLa cells were maintained in monolayer culture in
DMEM (Gibco-Invitrogen Corp.) 5% (v/v) fetal bovine
serum and 5% (v/v) calf serum (Gibco-Invitrogen Corp.).
Adenovirus type 5 was propagated in HeLa cells and titered
by plaque assay on the same cells as described previously
(Flint et al., 1975). Uninfected or Ad5-infected cells were
exposed to peptides added to the medium to final concen-
trations of 25 or 50 AM for 2–4 h at 37 -C.
Synthesis of biotinylated peptides
Peptides were synthesized on a model 433A Peptide
Synthesizer (Applied Biosystems) using FMOC Chemistry.
After the last FMOC protecting group had been removed on
the instrument, the peptide-resin with side-chain fully
protected was reacted off-line with biotin (Anaspec)
manually overnight. The biotinylated peptides were then
cleaved from the resin and deprotected with TFA. They
were purified using a Luna C18 preparative column
(Phenomenex) with an 0.1% TFA buffer system on a
reverse phase HPLC system (Agilent Technologies) The
purified, biotinylated peptides were analyzed on a LC/MS
system (A1100/MSD-Agilent Technologies) to confirm the
presence of biotin. They were dissolved in 0.01 M Hepes-
KOH, pH 7.9 containing 0.01 M NaCl and 10% (v/v)
dimethyl sulfoxide and stored in small portions at 20 -C.
Immunofluorescence
HeLa cells were seeded onto glass cover slips in the
wells of 6-well tissue culture dishes. When 80–90%
confluent, they were infected with 10 p.f.u./cell Ad5.
Uninfected and infected cells were fixed with 4% (v/v)
paraformaldehyde in phosphate-buffered saline (PBS,
S.J. Flint et al. / Virology 337 (2005) 7–17 15Gibco-Invitrogen Corp.), permeabilized with 0.5% (v/v)
Triton X-100 in the same buffer, and blocked as described
by Ornelles and Shenk (1991). Biotin-labeled peptides and
the viral E1B 55 kDa protein were detected using FITC-
avidin (Santa Cruz Biotechnology) and monoclonal anti-
body 2A6 (Sarnow et al., 1984) IgG labeled with Alexa-
Flour 488 (Molecular Probes), respectively. Approximately
1 mg purified 2A6 IgG was stirred for 1 h at room
temperature with AlexaFlour 488 reactive dye in 0.10 M
sodium bicarbonate. The labeled antibody and unreacted
dye were then separated by gel filtration chromatography in
0.01 M potassium phosphate, pH 7.2, containing 0.15 M
NaCl and 0.2 M sodium azide. The degree of labeling, in
this case 3.3 mol dye/mol protein, was determined accord-
ing to the manufacturer’s protocol. The viral 72-kDa single-
stranded DNA-binding protein was examined by indirect
staining using a monoclonal antibody against the DBP (B6,
Reich et al., 1983) and Cy5-labeled goat anti-mouse IgG
(Jackson ImmunoResearch Laboratories Inc.). After incu-
bation with these reagents, cells were stained with DAPI,
washed with PBS, and mounted as described previously
(Gonzalez and Flint, 2002). They were examined using a
Zeiss LSM 510 confocal microscope with a C-Apochromat
40  1.2 NA water immersion objective.
Analysis of E1B 55 kDa protein shuttling
HeLa cells were infected with 10 p.f.u./cell Ad5. After
adsorption of virus particles for 1 h at 37 -C, the inoculum
was removed and the cells washed twice with PBS and
removed from the dish by trypsinization. The infected cells
were mixed with an equal number of uninfected HeLa cells
and plated on cover slips as described above. At 12–14 h
after infection, they were fused by exposure for 2 min to
50% polyethylene glycol (Gibco-Invitrogen Corp.) They
were then incubated in medium containing 100 Ag/ml
cycloheximide and no peptide, or the NES or NESm
peptides (Fig. 1) for 2–4 h at 37 -C. The locations of the
viral E1B 55 kDa and the viral DBP were then examined by
immunofluorescence as described in the previous section.
Immunoblotting
Cytoplasmic and nuclear fractions of Ad5-infected cells
were prepared by two extractions with 0.01 M Tris–HCl,
pH 7.5, containing 0.15 M NaCl, 1 mM EDTA, and 0.065%
(v/v) NP40, as described previously (Gonzalez and Flint,
2002). The proteins present in cytoplasmic extracts obtained
from equal numbers of infected cells that were untreated or
exposed to 50 AM NES or NESm peptides were separated
by electrophoresis in 10% polyacrylamide–SDS gels. They
were then transferred to 0.2 A nitrocellulose membranes
(Schleicher and Schuell) using the semi-dry method. The
E1B-55 kDa and human h-actin proteins were detected
using the 2A6 monoclonal antibody described above and
mouse monoclonal antibody AC-15 (abcam), respectively,and chemiluminescence (ECL plus, Amersham Biosciences).
Signals were quantified using NIH Image software.
Export of viral late mRNA
Export efficiencies were determined as the ratios of
cytoplasmic to nuclear concentrations of the viral L2 penton
and L5 fiber mRNAs (Gonzalez and Flint, 2002). These
concentrations were measured using real-time RT-PCR.
Reverse transcription was performed manually using pri-
mers complementary to the splice junctions between the ML
tripartite leader sequence and the bodies of L2 penton or L4
fiber mRNAs. Both primers were complementary to 11
bases upstream of the splice sites and the penton and fiber
primers were complementary to 12 and 14 bases, respec-
tively, downstream of the splice junctions. Reactions were
as described previously (Gonzalez and Flint, 2002), and
contained 5–10 Ag RNA, 15 pmol of ML penton or fiber
primers, and 4.5 pmol of the reverse primer of a human
h-actin amplicon (Applied Biosystems). Multiplex, real-
time PCR was carried out using the ABI Prism 7700
sequence detections system and TaqMan (Applied Biosys-
tems) probes of an amplicon within the ML tripartite leader
sequence designed using Primer Express software (Applied
Biosystems) and the human h-actin amplicon mentioned
above, labeled with VIC and FAM, respectively. The ML
amplicon comprised a forward primer corresponding to
positions 69–90 of the tripartite leader sequence, a reverse
primer complementary to positions 133–150, and a probe
corresponding to positions 94–114. Relative RNA concen-
trations were determined by the standard curve method.Acknowledgments
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